March 19 (Reuters) - CSL Ltd (CSL) :
- FERINJECT® APPROVED BY HEALTH CANADA FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN ADULT AND PEDIATRIC PATIENTS AND IRON DEFICIENCY IN ADULT PATIENTS WITH HEART FAILURE
- CSL LTD: IN CANADA, FERINJECT IS COMMERCIALIZED THROUGH CSL BEHRING CANADA, INC., WITH AVAILABILITY EXPECTED IN SECOND HALF OF 2024
News: CSL Ferinject Approved By Health Canada For The Treatment Of Iron Deficiency Anemia In Adult...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$276.00 |
Change
-2.200(0.79%) |
Mkt cap ! $132.9B | |||
| Open | High | Low | Value | Volume |
| $277.56 | $278.00 | $275.04 | $33.71M | 121.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 16 | $276.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $276.02 | 1 | 1 |
View Market Depth
| Last trade - 11.00am 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$276.76 |
Change
-2.200 ( 0.87 %) |
||||
| Open | High | Low | Volume | ||
| $277.51 | $278.00 | $275.04 | 11876 | ||
| Last updated 11.19am 30/05/2024 ? | |||||
| CSL (ASX) Chart |